Quality assurance in human papillomavirus testing for primary cervical screening

Area of Science:

• Oncology
• Public Health
• Molecular Diagnostics

Background:

• Cervical cancer screening recommendations increasingly emphasize human papillomavirus (HPV) molecular testing.
• Effective implementation of HPV-based screening necessitates robust quality assurance (QA) systems.
• Global applicability of QA recommendations is vital, particularly for low- and middle-income countries.

Purpose of the Study:

• To outline essential quality assurance considerations for HPV-based cervical screening programs.
• To provide guidance on selecting, implementing, and utilizing HPV screening tests.
• To highlight the importance of QA systems and staff competence in HPV screening.

Main Methods:

• Summarization of key quality assurance principles for HPV screening.
• Focus on test selection, implementation, and usage protocols.
• Inclusion of internal quality control, external quality assessment, and staff training.

Main Results:

• Key QA components identified for HPV screening include test selection, implementation, and ongoing use.
• Essential QA systems encompass internal quality control and external quality assessment processes.
• Staff competence and training are critical factors for successful HPV screening programs.

Conclusions:

• Implementing comprehensive quality assurance is essential for maximizing the benefits of HPV-based cervical screening.
• Awareness of critical QA issues is necessary for all screening settings, even if full implementation is challenging.
• Internationally recognized QA recommendations should be adaptable to various healthcare contexts.